Moreover, GBM cells treated with MMP2/9 inhibitors have a rounded-ameboid mode of invasion, whereas the inhibition of HA synthases (HASs) promotes the morphological transition from a rounded-amoeboid to an elongated-mesenchymal morphology [73]. Here, MMP2 is linked to glioblastoma.